These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 31493211)

  • 1. Multiparametric PET/MR (PET and MR-IVIM) for the evaluation of early treatment response and prediction of tumor recurrence in patients with locally advanced cervical cancer.
    Gao S; Du S; Lu Z; Xin J; Gao S; Sun H
    Eur Radiol; 2020 Feb; 30(2):1191-1201. PubMed ID: 31493211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early treatment response of patients undergoing concurrent chemoradiotherapy for cervical cancer: An evaluation of integrated multi-parameter PET-IVIM MR.
    Xu C; Sun H; Du S; Xin J
    Eur J Radiol; 2019 Aug; 117():1-8. PubMed ID: 31307633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of integrated PET-IVIM MR in assessing metastases in hypermetabolic pelvic lymph nodes in cervical cancer: a multi-parameter study.
    Xu C; Du S; Zhang S; Wang B; Dong C; Sun H
    Eur Radiol; 2020 May; 30(5):2483-2492. PubMed ID: 32040728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Value of Pretreatment Metabolic PET Parameters in Cervical Cancer Patients With Metabolic Complete Response After Concurrent Chemoradiotherapy.
    Son SH; Jeong SY; Chong GO; Lee YH; Park SH; Lee CH; Hong CM; Jeong JH; Lee SW; Ahn BC; Lee J
    Clin Nucl Med; 2018 Sep; 43(9):e296-e303. PubMed ID: 30036243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of treatment response in patients with locally advanced cervical cancer using midtreatment PET/MRI during concurrent chemoradiotherapy.
    Vojtíšek R; Baxa J; Kovářová P; Almortaza A; Hošek P; Sukovská E; Tupý R; Ferda J; Fínek J
    Strahlenther Onkol; 2021 Jun; 197(6):494-504. PubMed ID: 33492444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of
    Rufini V; Collarino A; Calcagni ML; Meduri GM; Fuoco V; Pasciuto T; Testa AC; Ferrandina G; Gambacorta MA; Campitelli M; Gui B; Zannoni G; Manfredi R; Scambia G; Giordano A
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1228-1238. PubMed ID: 31414206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combinative evaluation of primary tumor and lymph nodes to predict pelvic lymphatic metastasis in cervical cancer: an integrated PET-IVIM MRI study.
    Xu C; Li X; Shi Y; Wang B; Sun H
    Cancer Imaging; 2020 Mar; 20(1):21. PubMed ID: 32143736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between
    Du S; Sun H; Gao S; Xin J; Lu Z; Chen Z; Pan S; Guo Q
    Clin Radiol; 2019 Mar; 74(3):178-186. PubMed ID: 30545566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre- and per-treatment 18F-FDG PET/CT parameters to predict recurrence and survival in cervical cancer.
    Leseur J; Roman-Jimenez G; Devillers A; Ospina-Arango JD; Williaume D; Castelli J; Terve P; Lavoue V; Garin E; Lejeune F; Acosta O; De Crevoisier R
    Radiother Oncol; 2016 Sep; 120(3):512-518. PubMed ID: 27569847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of FDG PET metabolic tumour volume versus ADC histogram: prognostic value of tumour treatment response and survival in patients with locally advanced uterine cervical cancer.
    Ueno Y; Lisbona R; Tamada T; Alaref A; Sugimura K; Reinhold C
    Br J Radiol; 2017 Jul; 90(1075):20170035. PubMed ID: 28508679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of integrated PET-IVIM MRI in predicting lymphovascular space invasion in cervical cancer without lymphatic metastasis.
    Xu C; Yu Y; Li X; Sun H
    Eur J Nucl Med Mol Imaging; 2021 Aug; 48(9):2990-3000. PubMed ID: 33506309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-treatment prediction of early response to chemoradiotherapy by quantitative analysis of baseline staging FDG-PET/CT and MRI in locally advanced cervical cancer.
    Min LA; Ackermans LL; Nowee ME; Griethuysen JJV; Roberti S; Maas M; Vogel WV; Beets-Tan RG; Lambregts DM
    Acta Radiol; 2021 Jul; 62(7):940-948. PubMed ID: 32722967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoradiotherapy for locally advanced cervix cancer without aortic lymph node involvement: can we consider metabolic parameters of pretherapeutic FDG-PET/CT for treatment tailoring?
    Voglimacci M; Gabiache E; Lusque A; Ferron G; Ducassou A; Querleu D; Motton S; Chantalat E; Courbon F; Martinez A
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1551-1559. PubMed ID: 30729273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the Prognostic Value of F-18 Pet Metabolic Parameters of Primary Tumors and Regional Lymph Nodes in Patients with Locally Advanced Cervical Cancer Who Are Treated with Concurrent Chemoradiotherapy.
    Chong GO; Jeong SY; Park SH; Lee YH; Lee SW; Hong DG; Kim JC; Lee YS; Cho YL
    PLoS One; 2015; 10(9):e0137743. PubMed ID: 26368542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combinative evaluation of primary tumor and lymph nodes in predicting pelvic lymphatic metastasis in early-stage cervical cancer: A multiparametric PET-CT study.
    Li K; Sun H; Guo Q
    Eur J Radiol; 2019 Apr; 113():153-157. PubMed ID: 30927941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of posttreatment
    Lima GM; Matti A; Vara G; Dondi G; Naselli N; De Crescenzo EM; Morganti AG; Perrone AM; De Iaco P; Nanni C; Fanti S
    Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2139-2146. PubMed ID: 30069578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic parameters with different thresholds for evaluating tumor recurrence and their correlations with hematological parameters in locally advanced squamous cell cervical carcinoma: an observational
    Du S; Sun H; Gao S; Xin J; Lu Z
    Quant Imaging Med Surg; 2019 Mar; 9(3):440-452. PubMed ID: 31032191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of outcome using pretreatment
    Lucia F; Visvikis D; Desseroit MC; Miranda O; Malhaire JP; Robin P; Pradier O; Hatt M; Schick U
    Eur J Nucl Med Mol Imaging; 2018 May; 45(5):768-786. PubMed ID: 29222685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of local relapse and distant metastasis in patients with definitive chemoradiotherapy-treated cervical cancer by deep learning from [
    Shen WC; Chen SW; Wu KC; Hsieh TC; Liang JA; Hung YC; Yeh LS; Chang WC; Lin WC; Yen KY; Kao CH
    Eur Radiol; 2019 Dec; 29(12):6741-6749. PubMed ID: 31134366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic activity determines survival depending on the level of lymph node involvement in cervical cancer.
    Martinez A; Chantalat E; Angeles MA; Ferron G; Ducassou A; Daix M; Attal J; Bétrian S; Lusque A; Gabiache E
    BMC Cancer; 2022 Jul; 22(1):810. PubMed ID: 35870900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.